Kyle Doherty


Updates in Lung Cancer Screening Criteria Increase African American Patient Participation

July 06, 2022

The expansion of screening criteria is an important step in decreasing lung cancer screening disparities in high-risk populations. Efforts to expand community outreach, overcome logistical barriers, and facilitate screening adherence must still be made, experts say.

Venetoclax/Obinutuzumab Continues to Show Efficacy in Unfit Patients with CLL

June 30, 2022

An updated safety and efficacy analysis of the ongoing CLL14 trial showed that venetoclax plus obinutuzumab continues to be an effective treatment for patients with chronic lymphocytic leukemia and coexisting conditions.